Celebrex risky in high-risk patients, study finds
CHICAGO (Reuters) - Doctors should prescribe the lowest doses of Celebrex possible in patients at high risk of heart problems, researchers who did a combined analysis of six studies of the Pfizer Inc pain drug said on Monday.
More: continued here
Leave a Reply
You must be logged in to post a comment.